Infinium Pharmachem Ltd (INFM)

Currency in INR
256.35
-13.50(-5.00%)
Closed·

INFM Financial Summary

Key Ratios

P/E Ratio47.73
Price/Book7.17
Debt / Equity23.96%
Return on Equity14.99%
Dividend Yield0.00%
EBITDA185.91M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
3.17 / --
Revenue / Forecast
829.81M / --
EPS Revisions
Last 90 days

FAQ

What were Infinium Pharmachem's earnings for the latest quarter?

The Infinium Pharmachem EPS (TTM) is 6.83. Infinium Pharmachem reported sales of 829.81, net income of 44.06, and EPS of 3.17 for the latest quarter.

What was Infinium Pharmachem's net income for the latest quarter?

Infinium Pharmachem's net income for the latest quarter was 44.06.

How did Infinium Pharmachem's performance compare year-over-year in the latest quarter?

The company's revenue moved from 741.57 in the previous quarter to 829.81 in the latest quarter, and net income moved from 50.94 to 44.06 compared to the previous quarter.

What is Infinium Pharmachem's net profit margin on a TTM basis?

Infinium Pharmachem's trailing twelve months (TTM) net profit margin is 8.33%.

How does Infinium Pharmachem's debt to equity ratio compare to industry standards?

Infinium Pharmachem's total debt-to-equity ratio is 23.96%.

What is Infinium Pharmachem's return on investment on a TTM basis?

Infinium Pharmachem's trailing twelve months (TTM) return on investment (ROI) is 14.99%.

Did Infinium Pharmachem gain or lose cash last quarter?

In the latest quarter, Infinium Pharmachem's net change in cash was 38.40 million.

What were Infinium Pharmachem's total assets and liabilities in the latest quarter?

As of the latest quarter, Infinium Pharmachem reported total assets of 1,338.55 million and total liabilities of 300.09 million.

How has Infinium Pharmachem's total revenue grown this year?

Infinium Pharmachem's total revenue was 741.57 in the previous quarter and 829.81 in the latest quarter.

What is Infinium Pharmachem's gross margin on a TTM basis?

Infinium Pharmachem's trailing twelve months (TTM) gross margin is 20.90%.

What was Infinium Pharmachem's revenue per share for the latest quarter?

Infinium Pharmachem's revenue per share for the latest quarter was 433.61.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.